Keywords: curatek, files, nda, metrogel-v, illinois, usa-based, pharma-ceuticals
CURATEK FILES NDA FOR METROGEL-V
Article | 20 April 1992
Illinois, USA-based Curatek Pharma-ceuticals has submitted a New Drug Application to the Food and Drug Administration for a topical formulation ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Is failure to adopt business process management putting the pharma industry at risk?
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
- New Zealand declines Alexion's funding application for Solaris
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
